MedTrace Logo

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

NCT00216931 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-02-04

No results posted yet for this study

Summary

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

Conditions

  • Persistent Pulmonary Hypertension
  • Respiratory Distress Syndrome

Interventions

DRUG

iloprost

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Lund University Hospital

    lead OTHER

Principal Investigators

  • Vineta Fellman, Professor · Lund University Hospital, Department of Pediatrics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Hours
Max Age
48 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2008-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00216931 on ClinicalTrials.gov